SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001178913-23-000360
Filing Date
2023-02-02
Accepted
2023-02-02 14:23:25
Documents
1
Group Members
ARKIN BIO VENTURE PARTNERS LTD.ARKIN BIO VENTURES LIMITED PARTNERSHIP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A zk2923109.htm SC 13G/A 88330
  Complete submission text file 0001178913-23-000360.txt   89622
Mailing Address 6 HACHOSHLIM ST. HERZELIA L3 4672406
Business Address
Arkin Moshe (Filed by) CIK: 0001321178 (see all company filings)

Type: SC 13G/A

Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421
Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297
Keros Therapeutics, Inc. (Subject) CIK: 0001664710 (see all company filings)

IRS No.: 811173868 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91484 | Film No.: 23580173
SIC: 2834 Pharmaceutical Preparations